Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies.

Keywords

RANKL, Osteoclast, Bone resorption, RANK Ligand, Medicine

References

• A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.L. Sinigaglia, A Nervetti, Quirico Mela — 2000
• Predictive factors for the longterm outcome of spondyloarthropathies.B Amor, Raquel Sánchez Santos, Roula Said Nahal — 1994
• Treatment update on spondyloarthropathyAllen Anandarajah, Christopher T. Ritchlin — 2004
• Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytesKlaus Bobacz, A. Soleiman, W. Graninger — 2001
• Identification of genes associated with the presence of ectopic lymphoid structures in rheumatoid arthritis synovial tissuesBelinda Baltus, Reina E. Mebius, Mark F. R. Vondenhoff — 2005
• HIF-1 mediated upregulation of VEGF and VEGF-R in systemic sclerosis (SSc): Imbalance with angiostatic factors suggests VEGF as a novel option for the treatment of ischemia in patients with SScOliver Distler, Annette Scheid, Arturo Rosso — 2002
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionDirk Anderson, Eugene Maraskovsky, William L. Billingsley — 1997
• Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.E M Gravallese, Y. Harada, J T Wang — 1998
• Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandYoung‐Yun Kong, Ulrich Feige, Iidiko Sarosi — 1999
• Bone mineral density in patients with psoriatic arthritis.Bruno Frediani, A. Allegri, Paolo Falsetti — 2001
• The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure.H. Kalervo Väänänen, M.A. Horton — 1995
• Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.Johannes Grisar, P. Bernecker, Martin Aringer — 2002
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.Sjef van der Linden, Hans A. Valkenburg, A. Cats — 1984
• Bone resorption by osteoclasts.Steven L. Teitelbaum — 2000
• Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).H.-R. Kim, H.-Y. Kim, Seung‐Hwan Lee — 2006
• Imbalance of Osteoclastogenesis‐Regulating Factors in Patients With Celiac DiseaseAnna Taranta, Dario Fortunati, Maurizio Longo — 2004
• Malignant Autosomal Recessive Osteopetrosis Caused by Spontaneous Mutation of Murine RankRaj P. Kapur, Zhenqiang Yao, Malissa H.K Iida — 2004
• The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density.D K Mitra, D. M. Elvins, D J Speden — 2000
• Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosisAtsuko Mizuno, Takeshi Kanno, M. Hoshi — 2002
• Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulationGaoping Chen, Kanishka Sircar, Armen Aprikian — 2006

Cited by

• IL-4 Modulates Macrophage Polarization in Ankylosing SpondylitisShishui Lin, Meiguang Qiu, Jianting Chen — 2015
• NSAIDs can have adverse effects on bone healing.Robert W. van Esch, Maurice M. Kool, Saskia van As — 2013
• Mechanisms of tissue damage in arthritisStephan Blüml, Kurt Redlich, Josef S Smolen — 2014
• hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63Xi Zhao, Yong-lie Chao, Pixiu Chen — 2012
• Pathogenesis of axial spondyloarthropathy in a network perspectiveJing Zhao, Jie Chen, Tinghong Yang — 2011
• Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cellsStephan Blüml, Martin Friedrich, Tobias Lohmeyer — 2013
• Insights into the pathogenesis of axial spondyloarthropathy from network and pathway analysisJing Zhao, Jie Chen, Ting-Hong Yang — 2012
• Modulation of Signaling Molecules by Human Leucocyte Antigen B27; Special Reference to STAT1Marja Ruuska — 2014
• Why platelet-rich plasma failed to promote bone healing in combination with a biphasic synthetic graft material in bone defects: a critical comment.Tie‐Lou Chen, Huijie Lu — 2014
• Low level laser therapy accelerates bone healing in spinal cord injured rats.Carla Christina Medalha, Ana Lúcia Yaeko da Silva Santos, Suellen Veronez — 2016
• Echinocystic acid inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and ERK signaling pathways.Jian-hui Yang, Bing Li, Qiong Wu — 2016
• Frequency of low bone mineral density in spondyloarthropathy presenting at a tertiary care hospital.Lubna Nazir, Shafique ur rehman, Amir Riaz — 2015
• Pathophysiology of hemophilic arthropathy and potential targets for therapyAstrid E. Pulles, S.C. Mastbergen, Roger E. G. Schutgens — 2017
• Osteoconductive properties of two different bioactive glass forms (powder and fiber) combined with collagenAngela Maria Paiva Magri, Kelly Rossetti Fernandes, Fabio Roberto Ueno — 2017
• The multifaceted link between inflammation and human diseasesPeramaiyan Rajendran, Ya‐Fang Chen, Yu‐Feng Chen — 2018
• The impact of osteoporosis in patients with ankylosing spondylitis and its relationship to physical activityAbdulkareemShehab Diab — 2018
• In vitro and in vivo genotoxicity and cytotoxicity analysis of protein extract from Aplysina fulva spongesAlan de França Santana, Ingrid Regina Avanzi, Júlia Risso Parisi — 2021
• C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked OsteoclastogenesisJing Wang, Fanyu Zhao, Linshan Xu — 2023
• ASSESSMENT OF THE RATE OF MINERAL DENSITY IN BONES AND THE FACTORS CONTRIBUTING TO LOW BONE DENSITY IN PEOPLE SUFFERING FROM SPONDYLOARTHROPATHIESM. Nasir, M. Shahnawaz, M. Naeem — 2019
• Erratum to: hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63Xi Zhao, Yonglie Chao, Pixiu Chen — 2011

Related papers

• The effects of tumor necrosis factor-α on osteoclast formation depend on the haematopoietic precursorsJeannette Portenier, Silvia Dolder, Antoinette Wetterwald — 2006
• TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathwayGang Luo, Fangfei Li, Xiaoming Li — 2018
• Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.Aiichiro Yamamoto, Tsuyoshi Miyazaki, Yuho Kadono — 2002
• Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal KinaseJung‐Yoon Choe, Ki-Yeun Park, Seong‐Kyu Kim — 2015
• An inhibitory role for caspase‐3 at the late stage of RANKL‐induced osteoclast differentiation in RAW264 cells and mouse bone marrow macrophagesYuko Katao, Mika Shishido, Kaoru Inami — 2014
• Stimulation of Osteoclast Formation by RANKL Requires Interferon Regulatory Factor-4 and Is Inhibited by Simvastatin in a Mouse Model of Bone LossYoshiki Nakashima, Tatsuji Haneji — 2013
• Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways.Sakae Tanaka — 2013
• Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.Anne T. Mancino, V. Suzanne Klimberg, Matsuo Yamamoto — 2001
• Inhibition of RANK ligand: a new option for preventing fragility fractures.Giovanni Iolascon, Giuseppina Resmini, Umberto Tarantino — 2011